Share Name Share Symbol Market Type Share ISIN Share Description
Oryx International Growth Fund LSE:OIG London Ordinary Share GG00B3BTVQ94 ORD 50P
  Price Change % Change Share Price Shares Traded Last Trade
  -5.00p -0.64% 772.50p 6,934 13:35:46
Bid Price Offer Price High Price Low Price Open Price
760.00p 785.00p 777.50p 772.50p 777.50p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
General Financial 11.87 10.53 73.00 10.6 109.6

Oryx Growth Fund (OIG) Latest News

More Oryx Growth Fund News
Oryx Growth Fund Takeover Rumours

Oryx Growth Fund (OIG) Share Charts

1 Year Oryx Growth Fund Chart

1 Year Oryx Growth Fund Chart

1 Month Oryx Growth Fund Chart

1 Month Oryx Growth Fund Chart

Intraday Oryx Growth Fund Chart

Intraday Oryx Growth Fund Chart

Oryx Growth Fund (OIG) Discussions and Chat

Oryx Growth Fund Forums and Chat

Date Time Title Posts
21/5/201820:59Oryx International Growth Fund Ltd. (OIG)83
24/4/200906:33For those sad ex Baltimorers2
15/2/200817:22For those sad ex Balimorers-

Add a New Thread

Oryx Growth Fund (OIG) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2019-03-22 15:23:03765.003,50926,843.85O
2019-03-22 15:02:59760.002742,082.40O
2019-03-22 14:35:51765.001,98915,215.85O
2019-03-22 14:08:22778.003852,995.30O
2019-03-22 13:00:36779.0038296.02O
View all Oryx Growth Fund trades in real-time

Oryx Growth Fund (OIG) Top Chat Posts

Oryx Growth Fund Daily Update: Oryx International Growth Fund is listed in the General Financial sector of the London Stock Exchange with ticker OIG. The last closing price for Oryx Growth Fund was 777.50p.
Oryx International Growth Fund has a 4 week average price of 772.50p and a 12 week average price of 772.50p.
The 1 year high share price is 840p while the 1 year low share price is currently 745p.
There are currently 14,192,125 shares in issue and the average daily traded volume is 10,506 shares. The market capitalisation of Oryx International Growth Fund is £109,634,165.63.
stluke: News from NARS, ASTO and SPH today all resulting in the share price up, looking positive!
stluke: Only back to where we were the other day though, NAS which is also managed by Chris Mills via Harwood Capital has really pushed on over the past few months which you would have thought would have happened here as well as the portfolio has many of the same investments the biggest is actually OIG itself! Been doing some digging on the unquoted companies held by OIG and NAS via companies house and they look very promising, the NAS results to July 2012 mention that Bionostic Holdings Limited, Orthoproducts Limited and Nastor all of which OIG have interests in as well are all up for sale and I quote " the impact on the company's net asset value and cash position would be significant although there can be no guarantees" that they will be sold basically. The nature of unquoted investments will mean they have a much lower value placed on them by OIG and the market but if value is realised via a sale the impact could be significant to the share price.
stluke: Based on data as at 31st August as this was the last date holdings information is available, there was 9 stocks up 7 down and 1 unchanged in October of the UK quoted stocks. More importantly of the 6 largest holdings 5 were up and 1 unchanged. The star was definately MJ Gleeson (GLE) which is the 2nd largest holding and was up almost 12% which equates to approx £500,000 gain in value, the biggest holding CVS Group also had a strong month also adding approx £250,000 in value, they did also sold a quantity of this holding and locked in a decent gain. The worst performer QRT was down 6% but has recently rebounded on 3rd quarter update yesterday. Difficult to predict with any great accruacy the movement in terms of share price but should come in up again this month but nearer 8-10p, however this is subject to movement in valuation of the unquoted stocks.
stluke: Not a bad prediction if I don't say so myself! Seriously though it is good to see that my calculations are in the ballpark area and supported. Share price discrepency between market capital and NAV now standing at 67p and on course to grow further in October, share price will have to respond shortly but hopefully not before pay day!
stluke: It might not happen overnight but with so many of its holdings doing so well over the past 2 - 3 months its only a matter of time before it is represented in the sp, always a lag time on these stocks. Not only share price growth but dividend income has been very strong recently, one for example is CMX which recently paid 7p per share and with a holding in region of 3,500,000 shares that not bad. Looking to add further myself, if anyone can give me the details on Level 2 with number of brokers and prices in the morning it would be appreciated.
topvest: NAS has the same manager as Oryx - Harwood Capital led by Chris Mills. He has a strong long term record. JNY looks on the cusp of a major turnaround as it's now virtually debt free, focused on its 2 divisions and has also announced some major contract wins. The £12m market cap is a little undemanding given the £50m+ of revenue and an expected £1m profit. The business was a dog, but looks like things are going well which is not reflected in the share price. The activist holders will presumably want an exit so can see this doing well if it gets re-rated. They also have restructured the balance sheet and, if things are going well, there could be a hint of dividends around the corner.
stluke: Only a small holding for OIX but results from ESS very good today with share price up 29%! Edit - Now 50% up and could be the start of a strong recovery.
Oryx Growth Fund share price data is direct from the London Stock Exchange
Your Recent History
Oryx Growt..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190323 08:43:24